Overview

Nicotine Patch and Bupropion to Reduce Smoking Rates in Younger, Low-Income, and Minority Individuals

Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
Nicotine addiction is a serious health problem in the United States; 46 million people smoke cigarettes, and 70% of those are trying to quit. The nicotine patch and bupropion, a medication used to reduce nicotine cravings, are two commonly used smoking cessation aids. Both have been shown to reduce smoking rates, however, the effectiveness of combining the two treatments has not been widely examined. This study will evaluate the effectiveness of the nicotine patch combined with bupropion at reducing smoking rates among younger, low-income, and minority individuals.
Phase:
N/A
Details
Lead Sponsor:
University of Tennessee
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Bupropion
Nicotine